Skip to main content
Bio-Techne Corporation (TECH)
NASDAQ: TECH · Real-Time Price · USD
70.74
+0.36 (0.51%)
At close: Oct 29, 2024, 4:00 PM
71.49
+0.75 (1.06%)
After-hours: Oct 29, 2024, 5:10 PM EDT

Bio-Techne Revenue

In the fiscal year ending June 30, 2024, Bio-Techne had annual revenue of $1.16B with 1.97% growth. Bio-Techne had revenue of $306.10M in the quarter ending June 30, 2024, with 1.59% growth.

Revenue (ttm)
$1.16B
Revenue Growth
+1.97%
P/S Ratio
9.63
Revenue / Employee
$380,020
Employees
3,050
Market Cap
11.22B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20241.16B22.36M1.97%
Jun 30, 20231.14B31.10M2.81%
Jun 30, 20221.11B174.57M18.75%
Jun 30, 2021931.03M192.34M26.04%
Jun 30, 2020738.69M24.69M3.46%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Encompass Health 5.07B
Catalent 4.38B
Charles River Laboratories International 4.08B
AptarGroup 3.57B
Teleflex 3.01B
Royalty Pharma 2.24B
Globus Medical 2.24B
Neurocrine Biosciences 2.12B
Revenue Rankings

TECH News

More News